Workflow
Constellium Releases 2025 Sustainability Report, Shaping the Future of Sustainable Aluminum
Globenewswire· 2026-03-03 11:00
Ingrid Joerg, CEO of Constellium, said, "Achieving truly sustainable aluminum production requires continued innovation, collaboration, and focus. In 2025, we strengthened our safety performance, accelerated recycling, and made meaningful progress on decarbonization, while continuing to deliver for our customers. Our achievements reflect the dedication of our teams and the strength of our circular business model. We remain focused on driving measurable impact across our value chain." PARIS, March 03, 2026 (G ...
Hyperscale Data Bitcoin Treasury at 610.9188 Bitcoin; Cash and Bitcoin Holdings at Approximately 141.93% of Market Capitalization
Prnewswire· 2026-03-03 11:00
LAS VEGAS, March 3, 2026 /PRNewswire/ -- Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence ("AI") data center company anchored by Bitcoin ("Hyperscale Data" or the "Company"), today announced that its Bitcoin treasury, consisting of Bitcoin generated from mining operations and Bitcoin acquired in the open market, totaled approximately $40 million, based on the price of Bitcoin as of March 1, 2026. Additionally, as of the week ended March 1, 2026, the Company held approximately $41.5 mi ...
Esperion Therapeutics and Corstasis Therapeutics Announce Esperion's Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
Globenewswire· 2026-03-03 11:00
– Esperion to Host Conference Call on Tuesday, March 3, 2026 at 8:00 am ET – ANN ARBOR, Mich. and HENDERSON, Nev., March 03, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) and Corstasis Therapeutics Inc., a privately-held, commercial-stage biopharmaceutical company advancing innovative outpatient therapies for the treatment of edema associated with cardiovascular, and hepatic and renal disease, today announced they have entered into a definitive agreement for Esperion to acquire Corstasis. Under the terms ...
Restart Life Announces Collaboration with University of Manitoba's Centre for Food Technology and Research
TMX Newsfile· 2026-03-03 11:00
Vancouver, British Columbia--(Newsfile Corp. - March 3, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that, following the successful acquisition of Holy Crap Foods Inc., it has entered into a collaboration with the University of Manitoba's Richardson Centre for Food Technology and Research (RCFTR) to support a series of food-related scientific studies that will guide the Company's product development roadmap across its ...
Monroe Capital Selected as the 2025 CLO Manager of the Year by Private Debt Investor
Businesswire· 2026-03-03 11:00
CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC ("Monroe†) was selected as the recipient of the 2025 CLO Manager of the Year (Americas) by the Private Debt Investor ("PDI†) awards. PDI is a private markets publication, tracking the institutions, the funds, and the transactions shaping the private debt markets. PDI is published by PEI, the only global B2B information group focused exclusively on private equity, private debt, private real estate, infrastructure and agri investing. The Private Debt I. ...
Esperion Therapeutics and Corstasis Therapeutics Announce Esperion’s Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
Globenewswire· 2026-03-03 11:00
– Enbumyst™ Is the First and Only FDA-Approved Nasal Spray Loop Diuretic for Edema Associated with Congestive Heart Failure, Expected to Leverage Esperion's Established Cardiovascular Commercial Infrastructure, Synergistically Expand Product Portfolio and Accelerate Double-Digit Revenue Growth – The transaction is expected to close in the second quarter of 2026. "This acquisition represents a compelling and strategically aligned opportunity that accelerates Esperion's momentum and advances our long-term Vis ...
GDS to Report Fourth Quarter and Full Year 2025 Financial Results Before the Open of the U.S. Market on March 17, 2026
Globenewswire· 2026-03-03 11:00
SHANGHAI, China, March 03, 2026 (GLOBE NEWSWIRE) -- GDS Holdings Limited ("GDS Holdings", "GDS" or the "Company") (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high- performance data centers in China, today announced that it will report its fourth quarter and full year 2025 unaudited financial results after the close of the Hong Kong market and before the open of the U.S. market on March 17, 2026. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on ...
WEBCO INDUSTRIES, INC. REPORTS FISCAL 2026 SECOND QUARTER RESULTS
Prnewswire· 2026-03-03 11:00
WEBCO INDUSTRIES, INC. REPORTS FISCAL 2026 SECOND QUARTER RESULTS [Accessibility Statement] Skip NavigationSAND SPRINGS, Okla., March 3, 2026 /PRNewswire/ -- Webco Industries, Inc. (OTC: WEBC) today reported results for our second quarter of fiscal year 2026, which ended January 31, 2026.For our second quarter of fiscal year 2026, we had net income of $0.5 million, or $0.79 per diluted share, while in our second quarter of fiscal year 2025, we had a net loss of $2.0 million, or a loss of $2.91 per diluted s ...
Nasdaq 100: Tech Stocks Tumble Below 200-Day MA in Bearish Forecast
FX Empire· 2026-03-03 10:58
FX Empire Logo English check-icon Italiano Important DisclaimersFXEmpire is owned and operated by Empire Media Network LTD., Company Registration Number 514641786, registered at 7 Jabotinsky Road, Ramat Gan 5252007, Israel. The content provided on this website includes general news and publications, our personal analysis and opinions, and materials provided by third parties. This content is intended for educational and research purposes only. It does not constitute, and should not be interpreted as, a recom ...